FDA backs Pfizer COVID-19 boosters for seniors, high-risk

Virus Outbreak
Posted at 7:43 AM, Sep 23, 2021
and last updated 2021-09-23 07:45:00-04

The U.S. has moved a step closer to offering booster doses of Pfizer’s COVID-19 vaccine to seniors and others at high risk from the virus.

On Wednesday, The Food and Drug Administration signed off on such shots as a way to shore up protection in people with underlying health conditions and high-risk jobs.

This is not a done deal yet: The Centers for Disease Control and Prevention has yet to weigh in on who it believes should get boosters and when.

A panel of advisers to the agency will make more specific recommendations about who should get the extra shots and when.